Champoux Jennifer

Insider profile

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -29% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Champoux Jennifer's trades of Monte Rosa Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
361.02
Quantity 52,230
Value US$1,950,758
Transaction date
Proposed sale
Price
18.41
Quantity 2,175
Value US$40,042
Transaction date
Proposed sale
Price
17.93
Quantity 2,176
Value US$39,005
Transaction date
Proposed sale
Price
19.33
Quantity 2,175
Value US$42,043
Transaction date
Proposed sale
Price
18.72
Quantity 2,176
Value US$40,735
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-16 2026-07-15 PlS Planned sale
249 -39.3%
347.80
US$748,955
249 -39.3% 347.80 US$748,955
2026-07-15 2026-07-15 PrS Proposed sale
52,230
361.02
US$1,950,758
52,230 361.02 US$1,950,758
2026-06-25 2026-06-23 PlS Planned sale
20,548 -14.3%
382.82
US$1,069,530
20,548 -14.3% 382.82 US$1,069,530
2026-06-23 2026-06-23 PrS Proposed sale
2,175
18.41
US$40,042
2,175 18.41 US$40,042
2026-06-18 2026-06-17 PlS Planned sale
2,176 -3.4%
19.00
US$41,344
2,176 -3.4% 19.00 US$41,344
2026-06-17 2026-06-17 PrS Proposed sale
2,176
17.93
US$39,005
2,176 17.93 US$39,005
2026-05-28 2026-05-27 PlS Planned sale
2,175 -3.4%
20.00
US$43,500
2,175 -3.4% 20.00 US$43,500
2026-05-27 2026-05-27 PrS Proposed sale
2,175
19.33
US$42,043
2,175 19.33 US$42,043
2026-05-26 2026-05-22 PlS Planned sale
2,176 -3.4%
19.00
US$41,344
2,176 -3.4% 19.00 US$41,344
2026-05-22 2026-05-22 PrS Proposed sale
2,176
18.72
US$40,735
2,176 18.72 US$40,735
2026-01-05 2026-01-05 S Sale
2,629 -4.0%
15.17
US$39,882
2,629 -4.0% 15.17 US$39,882